Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
50.88
-0.34 (-0.66%)
At close: Dec 31, 2025, 4:00 PM EST
50.77
-0.11 (-0.22%)
After-hours: Dec 31, 2025, 7:59 PM EST
Novo Nordisk (NVO) Revenue by Segment
History
| Date | Diabetes | Obesity | Rare Disease |
|---|---|---|---|
| Jun 30, 2025 | 33.48B | 12.41B | 3.11B |
| Mar 31, 2025 | 33.26B | 11.39B | 2.96B |
| Dec 31, 2024 | 32.46B | 10.23B | 2.93B |
| Sep 30, 2024 | 31.12B | 8.63B | 2.75B |
| Jun 30, 2024 | 30.28B | 7.61B | 2.64B |
| Mar 31, 2024 | 28.66B | 7.04B | 2.67B |
| Dec 31, 2023 | 27.25B | 6.54B | 2.70B |
| Sep 30, 2023 | 25.31B | 5.64B | 2.74B |
| Jun 30, 2023 | 24.30B | 4.39B | 2.93B |
| Mar 31, 2023 | 23.13B | 3.35B | 3.10B |
| Dec 31, 2022 | 21.92B | 2.65B | 3.23B |
| Sep 30, 2022 | 20.89B | 2.17B | 3.20B |
| Jun 30, 2022 | 19.72B | 1.87B | 3.11B |
| Mar 31, 2022 | 18.72B | 1.61B | 3.08B |
| Dec 31, 2021 | 17.78B | 1.32B | 3.02B |
| Sep 30, 2021 | 16.59B | 1.12B | 2.98B |
| Jun 30, 2021 | 15.82B | 976.41M | 3.02B |
| Mar 31, 2021 | 15.50B | 890.02M | 3.00B |
| Dec 31, 2020 | 15.26B | 892.06M | 3.01B |
| Sep 30, 2020 | 15.80B | 949.55M | 3.14B |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.